These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Experimentally determined safety and immunological activity of vaccine based on antigens isolated from Pseudomonas aeruginosa in medium K-4]. Nuriddinova NR; Sheremet'ev NN; Ivanova LE; Garib FIu; Iskhakova KhI Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):57-60. PubMed ID: 16028515 [TBL] [Abstract][Full Text] [Related]
4. [Derivation and experimental evaluation of polyvalent corpuscular vaccine for prevention of infections caused by Pseudomonas aeruginosa. I. Development of polyvalent corpuscular vaccine]. Moroz AF; Radkevich SA; Antsiferova NG; Brodinova NS Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):44-9. PubMed ID: 6171956 [No Abstract] [Full Text] [Related]
5. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines]. Stanislavskiĭ ES; Joó I; Bulk VF; Zhvanetskaia MI; Mashilova GM Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559 [TBL] [Abstract][Full Text] [Related]
6. [Experimental study of the protective activity of vaccines made from 7 Pseudomonas aeruginosa immunotypes]. Kholodkova EV; Fedotova IuM; Stanislavskiĭ ES Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):47-50. PubMed ID: 2446445 [TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa. II. Experimental acellular vaccine of an endotoxin and anatoxin type. Bĕlohlávek S; Pavlík V; Rencová J; Stránský V; Nováková L; Sourek J; Výmola F J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):343-52. PubMed ID: 3119704 [TBL] [Abstract][Full Text] [Related]
9. [Immunogenic properties and specificity of pseudomonas aeruginosa polyvalent vaccine]. Schiller B; Lysakowska E; Owczarska K Med Dosw Mikrobiol; 1981; 33(2):91-6. PubMed ID: 6170849 [No Abstract] [Full Text] [Related]
10. An acellular vaccine from Pseudomonas aeruginosa: homologous and crossed protection between serogroups according to Habs' classification. Berche P; Véron M; Fermanian J; Daoulas-Lebourdelles F; Guégen A Ann Microbiol (Paris); 1979; 130(2):179-88. PubMed ID: 90473 [TBL] [Abstract][Full Text] [Related]
11. Vaccines against Pseudomonas aeruginosa results and perspectives of investigations (survey). Joó I; Stanislavskii ES J Hyg Epidemiol Microbiol Immunol; 1982; 26(4):417-27. PubMed ID: 6819316 [TBL] [Abstract][Full Text] [Related]
12. Protective characteristics of the antigen common to Pseudomonas and Vibrio and significance of bacterial endotoxins in protection against selected bacterial infections. Sourek J Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Jul; 259(4):538-47. PubMed ID: 2413656 [TBL] [Abstract][Full Text] [Related]
13. [Cell-free Pseudomonas vaccine. III. Immunochemical analysis of purified Pseudomonas aeruginosa protein antigens and protective properties of antisera against these antigens]. Chekan LV; Stanislavskiĭ ES; Polkina NA Zh Mikrobiol Epidemiol Immunobiol; 1983 Feb; (2):92-6. PubMed ID: 6188300 [TBL] [Abstract][Full Text] [Related]
14. Immunisation with non-integral OMPs promotes pulmonary clearance of Pseudomonas aeruginosa. Thomas LD; Kyd JM; Bastin DA; Dunkley ML; Cripps AW FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):155-60. PubMed ID: 12832119 [TBL] [Abstract][Full Text] [Related]
15. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection. Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361 [TBL] [Abstract][Full Text] [Related]
17. Motility, virulence, and protection with a flagella vaccine against Pseudomonas aeruginosa infection. Montie TC; Drake D; Sellin H; Slater O; Edmonds S Antibiot Chemother (1971); 1987; 39():233-48. PubMed ID: 3118785 [No Abstract] [Full Text] [Related]
18. [Antigenic complexes of Pseudomonas aeruginosa slime: their isolation and biological properties]. Aleksandrov AD; Antsiferova NG; Zhmyrina TI; Moroz AF Zh Mikrobiol Epidemiol Immunobiol; 1984 Jan; (1):14-9. PubMed ID: 6422680 [TBL] [Abstract][Full Text] [Related]
19. Antigens of Pseudomonas aeruginosa and their use in immunoprophylaxis and immunotherapy. Stanislavsky ES; Dmitriev BA; Lányi B; Joó I Acta Microbiol Hung; 1985; 32(1):3-37. PubMed ID: 2412389 [No Abstract] [Full Text] [Related]
20. [Cell-free pseudomonas vaccine. I. Enzyme properties and virulence of strains of P. aeruginosa; protective activity of their water-soluble antigens]. Stanislavskiĭ ES; Zhvanetskaia MI; Mashilova GM; Gladus MA Zh Mikrobiol Epidemiol Immunobiol; 1980 Aug; (8):66-72. PubMed ID: 6778035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]